ALPS Group Inc Ordinary Share (NASDAQ:ALPS – Get Free Report) was the recipient of a significant decline in short interest during the month of June. As of June 30th, there was short interest totaling 14,273 shares, a decline of 39.3% from the June 15th total of 23,522 shares. Based on an average daily volume of 69,188 shares, the short-interest ratio is currently 0.2 days. Currently, 0.0% of the shares of the company are sold short.
Analysts Set New Price Targets
Separately, Weiss Ratings restated a “sell (e+)” rating on shares of ALPS Group Inc Ordinary Share in a report on Monday, July 6th. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, ALPS Group Inc Ordinary Share presently has an average rating of “Sell”.
Get Our Latest Report on ALPS Group Inc Ordinary Share
ALPS Group Inc Ordinary Share Price Performance
About ALPS Group Inc Ordinary Share
ALPS Group Inc is a fully integrated platform encompassing biotechnology research, medical, and wellness services specializing in predictive, precision and preventive health management. It aims to provide its clientele with access to DNA and mRNA sequencing, cellular therapy, as well as wellness and anti-aging products and services.
See Also
- Five stocks we like better than ALPS Group Inc Ordinary Share
- Which Storage Stock Is Best Positioned to Win the AI Memory War?
- Tesla’s Delivery Surprise Was Big—Earnings Need to Be Bigger
- Why Johnson & Johnson’s Earnings Dip Looks Like a Buying Opportunity
- CPI Comes In Cool: Why It Could Revive These 3 Rate-Sensitive Stocks
Receive News & Ratings for ALPS Group Inc Ordinary Share Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ALPS Group Inc Ordinary Share and related companies with MarketBeat.com's FREE daily email newsletter.
